Actemra 160mg, a drug known scientifically as tocilizumab, represents a potent biologic agent primarily used for the management of rheumatoid arthritis. This effective compound operates by inhibiting the activity of interleukin-6 (IL-6), a signaling protein vital in the inflammatory process. Additionally, Actemra exhibits efficacy in the control o